Falls During a 10-week Placebo-Controlled Study of Droxidopa for Neurogenic Orthostatic Hypotension in Parkinson's Disease

被引：0

作者：

Rowse, G. ^{[1
]}

Heritier, S. ^{[2
]}

Hewitt, L. ^{[1
]}

机构：

[1] Lundbeck LLC, Deerfield, IL USA

[2] Monash Univ, Melbourne, Vic 3004, Australia

来源：

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY | 2015年 / 63卷

关键词：

D O I：

暂无

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

03 ; 0303 ; 100203 ;

摘要：

A40

引用

页码：S31 / S31

页数：1

共 50 条

[21] Genetics of Neurogenic Orthostatic Hypotension in Parkinson's Disease
Chevalier, G.
Udovin, L.
Otero-Losada, M.
Bordet, S.
Capani, F.
Luo, S.
Goetz, C.
Perez-Lloret, S.
MOVEMENT DISORDERS, 2023, 38 : S469 - S470
[22] Orthostatic Hypotension, Balance and Falls in Parkinson's Disease
Matinolli, Maarit
Korpelainen, Juha T.
Korpelainen, Raija
Sotaniemi, Kyosti A.
Myllyla, Vilho V.
MOVEMENT DISORDERS, 2009, 24 (05) : 745 - 751
[23] Placebo-controlled 10-week prospective comparison of the occurrence of falls in dementia: Olanzapine versus risperidone
Hoffmann, VP
Kennedy, JS
Young, CA
Feldman, PD
Deberdt, W
INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 265 - 266
[24] Erratum to: Titrating droxidopa to maximize symptomatic benefit in a patient with Parkinson disease and neurogenic orthostatic hypotension
Fiona Gupta
Beverly Karabin
Ali Mehdirad
Clinical Autonomic Research, 2017, 27 : 431 - 431
[25] Impact of neurogenic orthostatic hypotension on healthcare utilization and costs associated with falls in Parkinson's disease
Francois, C.
Biaggioni, I.
Shibao, C. A.
Ogbonnaya, A.
Shih, H. -C.
Farrelly, E.
Ziemann, A.
Duhig, A.
MOVEMENT DISORDERS, 2016, 31 : S147 - S147
[26] Patient-Reported Falls and Fear of Falling in a Prospective Study of Droxidopa for Treatment of Neurogenic Orthostatic Hypotension
Kymes, Steven
Francois, Clement
McLeod, Kim
Duhig, Amy
Ogbonnaya, Augustina
Quillen, Apryl
Cannon, Joan
Shibao, Cyndya
Yue, Binglin
Hauser, Robert
Biaggioni, Italo
MOVEMENT DISORDERS, 2018, 33 : S52 - S52
[27] Patient-Reported Falls and Fear of Falling in a Prospective Study of Droxidopa for Treatment of Neurogenic Orthostatic Hypotension
Kymes, Steve
Francois, Clement
McLeod, Kim
Duhig, Amy
Ogbonnaya, Augustina
Quillen, Apryl
Cannon, Joan
Shibao, Cyndya A.
Yue, Binglin
Hauser, Robert A.
Biaggioni, Italo
NEUROLOGY, 2019, 92 (15)
[28] Integrated efficacy analysis of droxidopa in 2 double-blind, placebo-controlled phase 3 studies in patients with neurogenic orthostatic hypotension
Mathias, C.
Low, P.
Freeman, R.
Hewitt, A.
Kaufmann, H.
MOVEMENT DISORDERS, 2012, 27 : S426 - S426
[29] Impact of treatment with droxidopa in repeat fallers with Parkinson's disease and symptomatic neurogenic orthostatic hypotension (NOH 306A)
Hauser, R. A.
Schwieterman, W.
Isaacson, S.
MOVEMENT DISORDERS, 2012, 27 : S423 - S423
[30] Evaluation of droxidopa dosing and clinical response in 50 consecutive patients with Parkinson's disease and symptomatic neurogenic orthostatic hypotension
Isaacson, S. H.
Brillman, S.
Chhabria, N.
MOVEMENT DISORDERS, 2016, 31 : S679 - S680

← 1 2 3 4 5 →